Form 4: Walgreens Boots Alliance Director Acquires Phantom Stock Units

Valerie B. Jarrett, a director at Walgreens Boots Alliance, acquired 2,326.94 phantom stock units as part of her non-employee director compensation.

Summary

• Valerie B. Jarrett, a director at Walgreens Boots Alliance, acquired 2,326.94 phantom stock units on January 30, 2025.
• These phantom stock units were granted as part of her non-employee director compensation under the company's 2021 Omnibus Incentive Plan.
• Each phantom stock unit is economically equivalent to one share of Walgreens Boots Alliance common stock.
• The phantom stock units will be settled following the termination of her service as a director.
• The reported transaction also includes phantom stock units issued in lieu of dividends through January 31, 2025.
• Following the transaction, Ms. Jarrett beneficially owns 63,835.98 phantom stock units.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is a normal part of corporate governance. There are no indications of any negative or unusual activity.

Positives

• The acquisition of phantom stock units aligns the director's interests with those of the shareholders.
• The compensation structure is part of a pre-existing plan, indicating a consistent approach to director compensation.
• The inclusion of dividend equivalents in the phantom stock units provides additional value to the director.

Future Outlook

The phantom stock units will be settled following the termination of service as a director, in accordance with the terms of the 2021 Omnibus Incentive Plan.

Industry Context

This type of equity-based compensation is common for non-employee directors in publicly traded companies, aligning their interests with those of shareholders.

Comparison to Industry Standards

• Granting phantom stock units to non-employee directors is a standard practice among publicly listed companies, including those in the pharmaceutical and retail sectors.
• Companies like CVS Health and Rite Aid also use similar equity-based compensation plans for their directors.
• The number of units granted and the vesting schedule are generally aligned with industry benchmarks for director compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning director interests with company performance.
• The compensation structure is transparent and part of a pre-existing plan.

Key Dates

Keywords

phantom stock units, director compensation, Walgreens Boots Alliance, insider trading, SEC Form 4, equity compensation, non-employee director